Féron O - Search Results

1

Radioimmunotherapy with radioactive nanoparticles: first results of dosimetry for vascularized and necrosed solid tumors.

Bouchat V, Nuttens VE, Lucas S, Michiels C, Masereel B, Féron O, Gallez B, Vander Borght T. Bouchat V, et al. Among authors: feron o. Med Phys. 2007 Nov;34(11):4504-13. doi: 10.1118/1.2791038. Med Phys. 2007. PMID: 18072516

2

Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.

Lucas S, Feron O, Gallez B, Masereel B, Michiels C, Vander Borght T. Lucas S, et al. Among authors: feron o. Comput Math Methods Med. 2015;2015:284360. doi: 10.1155/2015/284360. Epub 2015 Jun 2. Comput Math Methods Med. 2015. PMID: 26136812 Free PMC article.

3

Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area.

Bouchat V, Nuttens VE, Michiels C, Masereel B, Feron O, Gallez B, Vander Borght T, Lucas S. Bouchat V, et al. Among authors: feron o. Med Phys. 2010 Apr;37(4):1826-39. doi: 10.1118/1.3368599. Med Phys. 2010. PMID: 20443505

4

Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death.

Radermacher KA, Magat J, Bouzin C, Laurent S, Dresselaers T, Himmelreich U, Boutry S, Mahieu I, Vander Elst L, Feron O, Muller RN, Jordan BF, Gallez B. Radermacher KA, et al. Among authors: feron o. NMR Biomed. 2012 Apr;25(4):514-22. doi: 10.1002/nbm.1765. Epub 2011 Aug 23. NMR Biomed. 2012. PMID: 21874657

5

Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.

Fruytier AC, Magat J, Neveu MA, Karroum O, Bouzin C, Feron O, Jordan B, Cron GO, Gallez B. Fruytier AC, et al. Among authors: feron o. NMR Biomed. 2014 Nov;27(11):1403-12. doi: 10.1002/nbm.3220. NMR Biomed. 2014. PMID: 25323069

6

Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death.

Radermacher KA, Boutry S, Laurent S, Elst LV, Mahieu I, Bouzin C, Magat J, Gregoire V, Feron O, Muller RN, Jordan BF, Gallez B. Radermacher KA, et al. Among authors: feron o. Contrast Media Mol Imaging. 2010 Sep-Oct;5(5):258-67. doi: 10.1002/cmmi.382. Contrast Media Mol Imaging. 2010. PMID: 20973111 Free article.

7

Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies.

Danhier P, De Preter G, Boutry S, Mahieu I, Leveque P, Magat J, Haufroid V, Sonveaux P, Bouzin C, Feron O, Muller RN, Jordan BF, Gallez B. Danhier P, et al. Among authors: feron o. Contrast Media Mol Imaging. 2012 May-Jun;7(3):302-7. doi: 10.1002/cmmi.497. Contrast Media Mol Imaging. 2012. PMID: 22539400 Free article.

8

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours.

Seront E, Boidot R, Bouzin C, Karroum O, Jordan BF, Gallez B, Machiels JP, Feron O. Seront E, et al. Among authors: feron o. Br J Cancer. 2013 Nov 12;109(10):2597-606. doi: 10.1038/bjc.2013.644. Epub 2013 Oct 24. Br J Cancer. 2013. PMID: 24157830 Free PMC article.

9

Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy.

Karroum O, Kengen J, Danhier P, Magat J, Mignion L, Bouzin C, Verrax J, Charette N, Starkel P, Calderon PB, Sonveaux P, Feron O, Grégoire V, Gallez B, Jordan BF. Karroum O, et al. Among authors: feron o. Radiother Oncol. 2012 Oct;105(1):64-71. doi: 10.1016/j.radonc.2012.05.005. Epub 2012 Jun 8. Radiother Oncol. 2012. PMID: 22682746

10

Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.

Schoonjans CA, Joudiou N, Brusa D, Corbet C, Feron O, Gallez B. Schoonjans CA, et al. Among authors: feron o. Cancer Lett. 2020 Feb 1;470:18-28. doi: 10.1016/j.canlet.2019.12.003. Epub 2019 Dec 5. Cancer Lett. 2020. PMID: 31812695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters